Oraya Therapeutics

Clinical Publications

Jackson, T. L., U. Chakravarthy, et al. (2013). “Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: 52-Week Safety and Efficacy Results of the INTREPID Study.” Ophthalmology Epub 2013 Mar 13.

Morales-Canton, V., H. Quiroz-Mercado, et al. (2013). “16 and 24 Gy Low-voltage X-ray Irradiation With Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes.” Am j Ophthalmol Epub 2013 Mar 13.

Moshfeghi, A. A., Morales-Canton, V. M., et al. “16-Gy Low-Voltage X-ray Irradiation Followed by As-Needed Ranibizumab Therapy for Age-Related Macular Degeneration: 12-Month Outcomes of a ‘Radiation-First’ Strategy.” Br j Ophthalmol 96.10 (2012):1320-4. Epub 2012 Aug 15.

Canton, V. M., Quiroz-Mercado, H., et al. “24-Gy Low-Voltage X-Ray Irradiation with Ranibizumab Therapy for Neovascular AMD: 6-Month Safety and Functional Outcomes.” Ophthalmic Surg Lasers Imaging 43.1 (2012):20-4.

Moshfeghi, A. A., Canton, V. M., et al. “16-Gy Low-Voltage X-ray Irradiation Followed by As-Needed Ranibizumab Therapy for AMD: 6-Month Outcomes of a “Radiation-First” Strategy.” Ophthalmic Surg Lasers Imaging 42.6 (2011):460-67.

Canton, V. M., Quiroz-Mercado, H., et al. “16-Gy Low-Voltage X-Ray Irradiation with Ranibizumab Therapy for Neovascular AMD: 6-Month Safety and Functional Outcomes.” Ophthalmic Surg Lasers Imaging 42.6 (2011):468-73.

Moshfeghi, A. A., Canton, V. M., et al. “16-Gy Low-Voltage X-ray Irradiation Followed by As-Needed Ranibizumab Therapy for AMD: 6-Month Outcomes of a “Radiation-First” Strategy.” Ophthalmic Surg Lasers Imaging 42.6 (2011):460-67.

Canton, V. M., Quiroz-Mercado, H., et al. “16-Gy Low-Voltage X-Ray Irradiation with Ranibizumab Therapy for Neovascular AMD: 6-Month Safety and Functional Outcomes.” Ophthalmic Surg Lasers Imaging 42.6 (2011):468-73.

Evans, J. R., Sivagnanavel, V., et al. “Radiotherapy for Neovascular Age-Related Macular Degeneration.” Cochrane Database Syst Rev 5 (2010):CD004004.

Finger, P. T., Gelman, Y. P., et al. “Palladium-103 Plaque Radiation Therapy for Macular Degeneration: Results of a 7-Year Study.” Br J Ophthalmol 87.12 (2003):1497-503.

Jaakkola, A., Heikkonen, J., et al. “Strontium Plaque Brachytherapy for Exudative Age-Related Macular Degeneration: Three-Year Results of a Randomized Study.” Ophthalmology 112.4 (2005):567-73.

Moshfeghi, D., Moshfeghi, A. A., et al. “Radiation Therapy for Age-Related Macular Degeneration.” Advanced Ocular Care Jul/Aug (2010): 33-7.

Moshfeghi, D. M., Kaiser, P. K., et al. “Stereotactic Low-Voltage X-Ray Irradiation for Age-Related Macular Degeneration.” Br J Ophthalmol 95.2 (2010):185-8.

Park, S. S., Daftari, I., et al. “Three-Year Follow-up of a Pilot Study of Ranibizumab Combined with Proton Beam Irradiation as Treatment for Exudative Age-Related Macular Degeneration.” Retina 2012 (Published ahead of print, Dec 16).

Petrarca, R. and Jackson, T., “Radiation Therapy for Neovascular Age-Related Macular Degeneration.” Clinical Ophthalmology 5 (2011):57-63.

Avila, M. P., Farah, M. E., et al. “Three-Year Safety and Visual Acuity Results of Epimacular 90strontium/90yttrium Brachytherapy with Bevacizumab for the Treatment of Subfovealchoroidal Neovascularization Secondary to Age-Related Macular Degeneration.” Retina 32.1 (2012):10-18.

Pre-Clinical and Technical Publications

Singh, R. P., Shusterman, E. M., et al. “Evaluation of Microcollimated Pars Plana External Beam Radiation in Porcine Eyes” J Experiment Ophthalmol 2.3 (2011)

Hanlon, J., Firpo, M., et al. “Stereotactic radiosurgery for AMD: A Monte Carlo-based assessment of patient-specific tissue doses.” Invest Ophthalmol Vis Sci 52 (2011):2334-42.

Hanlon, J., Lee, C., et al. “Kilovoltage Stereotactic Radiosurgery for Age-Related Macular Degeneration: Assessment of Optic Nerve Dose and Patient Effective Dose.” Med Phys 36.8 (2009): 3671-81.

Hasegawa, T., Kobayashi, T., et al. “Tolerance of the Optic Apparatus in Single-Fraction Irradiation Using Stereotactic Radiosurgery: Evaluation in 100 Patients with Craniopharyngioma.” Neurosurgery 66.4 688-94; discussion 694-5.

Miyamoto, H., Kimura, H., et al. “Effect of Focal X-Ray Irradiation on Experimental Choroidal Neovascularization.” Invest Ophthalmol Vis Sci 40.7 (1999):1496-502.

Taddei, P., Chell, E., et al. “Assessment of Targeting Accuracy of a Low-Energy Stereotactic Radiosurgery Treatment for Age-Related Macular Degeneration.” Phys Med Biol 55 2010:7037-7054.

Posters/Abstracts/White Papers/Presentations

Jackson, T. (2013). Stereotactic radiotherapy for the treatment of neo-vascular age-related macular degeneration: Year 2 results of the INTREPID trial. 13th EURETINA Congress, Hamburg, Germany.

Jackson, T. (2012). Responder Analysis of the INTREPID Study of Stereotactic Radiotherapy for Wet Age-Related Macular Degeneration. AAO, Chicago, IL, USA.

Jackson, T. (2012). Radiation for CNV: CABERNET/MERITAGE /INTREPID. AAO, Chicago, IL, USA.

Jackson, T. (2012). INTREPID Study: Stereotactic Radiotherapy for nvAMD. 12th EURETINA Congress, Milan, Italy

Moshfeghi, D. (2011). Treatment Durability and Vasculocidal Activity Following External Stereotactic Radiation for Wet AMD.Pan-American Association of Ophthalmology Congress 2011, Buenos Aires, Argentina.

Arnoldussen, M. E., Shusterman, M., et al. (2009). Quantitative Measurement of Retinal Structures Relative to the Geometric Axis of the Eye. ARVO, Ft. Lauderdale, FL, USA.

Arnoldussen, M. E., Shusterman, M., et al. (2010). Intraocular Pressure Measurement during Application of the Oraya I-Guide in Yucatan Mini-swine. ARVO, Ft. Lauderdale, FL, USA.

Chell, E., Arnoldussen, M. E., et al. (2011). Assessment of Motion Management in a Stereotactic Radiosurgical Device for the Treatment of Macular Degeneration. ARVO, Ft. Lauderdale, FL, USA.

Chell, E., Herron, M., et al. (2009). Dynamic Anthropomorphic Eye Phantoms for Targeting and Dose Verification of Novel Ophthalmic Radiosurgical Device. AAPM, Anaheim, CA, USA.

Firpo, M., Chell, E., et al. (2009). Dosimetry of a Novel Ophthalmic Stereotactic Radiosurgical Device. AAPM, Anaheim, CA, USA.

Firpo, M., Hanlon, J., et al. (2011). Simple Integrated Tissue-Air Ratio (SITAR): Determination of Depth Dose for a Narrow Field, Low Energy Ophthalmic Stereotactic Radiotherapy Device. AAPM, Vancouver, BC, Canada.

Hanlon, J., Chell, E., et al. (2011). Kilovoltage Stereotactic Radiosurgery for AMD: A More Complete Calculation of Effective Dose. AAPM, Vancouver, BC, Canada.

Moshfeghi, D., Pan, K. H., et al. (2009). Radiation Targeting and Dose Verification for Age-Related Macular Degeneration. ARVO, Ft. Lauderdale, FL, USA.

In the Press

Moshfeghi, A. “Radiation Therapy for Neovascular Age-related Macular Degeneration.” New Retina MD. Epub 2013 Apr.

King’s College Hospital. “King’s College Hospital First to Trial New Radiation Eye Treatment.” King’s College Hospital, NHS Foundation Trust 2010.

Haimovitch, L. (2009). OIS 2009 Report. Ophthalmology Innovations Summit, The Palace Hotel, San Francisco, CA.

Back To Top

Oraya Therapy Video Oraya Therapy Video
© 2014 All rights reserved. Oraya Therapeutics, Inc. The IRay® is a CE-marked medical device. The IRay is not available for sale in the United States. For additional details, including safety and risk information, please see the ORAYA THERAPY section of this website. Oraya, Oraya Therapy, IRay and I-Guide are either trademarks or registered trademarks of Oraya Therapeutics, Inc. in the United States and other countries.